Aquestive resubmits FDA application for Anaphylm epinephrine filmSep 17Clinical readoutAquestive Therapeutics, Inc.
Aquestive completes Anaphylm studies, keeps Q3 2026 NDA resubmission timelineAug 11Quarterly updateAquestive Therapeutics, Inc.
Aquestive reports positive human factors and PK data for Anaphylm ahead of NDA resubmissionAug 10Clinical readoutAquestive Therapeutics, Inc.
Sign in